Macrophage deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production.
[OBJECTIVE] Metadherin (MTDH) is a recognized oncogene involved in the progression and metastasis of various cancers.
APA
Jiang Y, Min L, et al. (2026). Macrophage deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production.. Journal for immunotherapy of cancer, 14(2). https://doi.org/10.1136/jitc-2025-013655
MLA
Jiang Y, et al.. "Macrophage deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production.." Journal for immunotherapy of cancer, vol. 14, no. 2, 2026.
PMID
41734995
Abstract
[OBJECTIVE] Metadherin (MTDH) is a recognized oncogene involved in the progression and metastasis of various cancers. However, further studies are needed to elucidate the biological role of MTDH, which is expressed in macrophages during tumor progression.
[METHODS] Mouse colorectal cancer and melanoma cells were subcutaneously and intravenously injected into myeloid-specific knockout mice to evaluate tumor growth and lung metastases. The effects of macrophage with knockout on angiogenesis and fibrosis were examined using mass spectrometry, immunofluorescence staining, analyses of data from The Cancer Genome Atlas (TCGA) colon adenocarcinoma and melanoma cohorts, and western blotting. A thrombospondin (TSP-1) blocking peptide was used to inhibit transforming growth factor β1 (TGF-β1) activation for suppression of fibrosis in vivo and in vitro. The molecular mechanisms were investigated using RNA sequencing data from the Gene Expression Omnibus database, ELISA, immunoprecipitation, chromatin immunoprecipitation assay, quantitative real-time PCR, and western blotting.
[RESULTS] -deficient macrophages suppressed lung metastasis but, unexpectedly, promoted subcutaneous tumor growth of both cancer cell types. This discordant effect was attributed to increased production of TSP-1, an angiogenesis inhibitor that also regulates fibrosis through TGF-β1 activation. knockout in macrophages inhibited angiogenesis in both lung metastatic and subcutaneous tumors, whereas enhanced fibrosis was observed only in subcutaneous tumors. In TCGA colon adenocarcinoma data, higher TSP-1 expression correlated with advanced pathological T stage and cancer-associated fibroblasts abundance. Furthermore, loss in macrophages induced activation of latent TGF-β1 in tumor cells, promoting fibroblast-to-myofibroblast transition, fibrosis, and unexpected tumor growth through the TSP-1/TGF-β1 axis. Mechanistically, MTDH deficiency led to nuclear retention of murine double minute-2 (MDM2), disruption of the MDM2-p53 interaction, and enhanced p53-dependent TSP-1 transcription.
[CONCLUSIONS] We found that macrophage deficiency discordantly regulates tumor metastasis and growth through either TSP-1-mediated anti-angiogenic effect or a TSP-1/TGF-β1-mediated pro-fibrotic effect. This study, therefore, provides novel insights into the mechanisms underlying the discordance between tumor growth and metastasis.
[METHODS] Mouse colorectal cancer and melanoma cells were subcutaneously and intravenously injected into myeloid-specific knockout mice to evaluate tumor growth and lung metastases. The effects of macrophage with knockout on angiogenesis and fibrosis were examined using mass spectrometry, immunofluorescence staining, analyses of data from The Cancer Genome Atlas (TCGA) colon adenocarcinoma and melanoma cohorts, and western blotting. A thrombospondin (TSP-1) blocking peptide was used to inhibit transforming growth factor β1 (TGF-β1) activation for suppression of fibrosis in vivo and in vitro. The molecular mechanisms were investigated using RNA sequencing data from the Gene Expression Omnibus database, ELISA, immunoprecipitation, chromatin immunoprecipitation assay, quantitative real-time PCR, and western blotting.
[RESULTS] -deficient macrophages suppressed lung metastasis but, unexpectedly, promoted subcutaneous tumor growth of both cancer cell types. This discordant effect was attributed to increased production of TSP-1, an angiogenesis inhibitor that also regulates fibrosis through TGF-β1 activation. knockout in macrophages inhibited angiogenesis in both lung metastatic and subcutaneous tumors, whereas enhanced fibrosis was observed only in subcutaneous tumors. In TCGA colon adenocarcinoma data, higher TSP-1 expression correlated with advanced pathological T stage and cancer-associated fibroblasts abundance. Furthermore, loss in macrophages induced activation of latent TGF-β1 in tumor cells, promoting fibroblast-to-myofibroblast transition, fibrosis, and unexpected tumor growth through the TSP-1/TGF-β1 axis. Mechanistically, MTDH deficiency led to nuclear retention of murine double minute-2 (MDM2), disruption of the MDM2-p53 interaction, and enhanced p53-dependent TSP-1 transcription.
[CONCLUSIONS] We found that macrophage deficiency discordantly regulates tumor metastasis and growth through either TSP-1-mediated anti-angiogenic effect or a TSP-1/TGF-β1-mediated pro-fibrotic effect. This study, therefore, provides novel insights into the mechanisms underlying the discordance between tumor growth and metastasis.
MeSH Terms
Animals; Thrombospondin 1; Mice; RNA-Binding Proteins; Humans; Macrophages; Membrane Proteins; Mice, Knockout; Neoplasm Metastasis; Cell Line, Tumor; Cell Adhesion Molecules; Lung Neoplasms; Neovascularization, Pathologic
같은 제1저자의 인용 많은 논문 (5)
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Juglans mandshurica-Eleutherococcus senticosus herb pair inhibits hepatocellular carcinoma growth by inducing immunogenic cell death via the HIF-1α/STAT3 pathway.
- A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma.
- Multi-omics study on tumor-associated macrophages remodeling the tumor microenvironment via the CXCL5-CXCR2 axis to drive immune escape in bladder cancer.
- RAC1 directly phosphorylates both PKM2 and FBP1 to promote radioresistance in hepatocellular carcinoma.